Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $6.29 | Prev. Close $6.28 | Circuit Range N/A |
Day Range $6.24 - $6.66 | Year Range $0.52 - $7.99 | Volume 1,44,790 |
Average Traded $6.43 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $6.29 | $6.38 | +0.00% |
10-Jun-26 | $6.29 | $6.38 | +1.75% |
09-Jun-26 | $5.80 | $6.28 | +9.89% |
08-Jun-26 | $6.05 | $5.71 | -4.03% |
05-Jun-26 | $6.29 | $5.95 | -5.71% |
04-Jun-26 | $6.36 | $6.31 | -0.16% |
03-Jun-26 | $6.43 | $6.32 | -1.48% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?